Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€183.96
17.12.21
€240.00
17.12.22
-37.46%
10.01.22

Could be worthwhile Investment >10% per year
Some uniques
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€32.60
16.12.21
-
16.12.22
38.19%
25.12.21

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€24.64
16.12.21
€33.00
31.12.23
-67.02%
07.09.22

Could be very worthwhile Investment >20% year
MagForce AG

Start price
Target price
Perf. (%)
€2.87
15.12.21
-
15.12.22
-99.93%
16.12.22

Revenue growth >5% per year expected
Probably not worthwhile Investment
High valuation
Risky balance sheet
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€0.98
14.12.21
-
14.12.22
-39.08%
15.12.22

Could be worthwhile Investment >10% per year
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€13.28
14.12.21
€0.000
14.12.22
-99.89%
20.02.22

Could be worthwhile Investment >10% per year
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.95
12.12.21
-
12.12.22
1.10%
25.12.21

Could be worthwhile Investment >10% per year
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.70
12.12.21
-
12.12.22
-5.19%
25.12.21

Could be worthwhile Investment >10% per year
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€12.89
12.12.21
-
12.12.22
7.45%
25.12.21

Could be worthwhile Investment >10% per year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€3.32
12.12.21
-
12.12.22
2.65%
25.12.21

Could be very worthwhile Investment >20% year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€45.60
12.12.21
-
12.12.22
23.60%
25.12.21

Could be very worthwhile Investment >20% year
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.26
12.12.21
-
12.12.22
9.82%
25.12.21

Could be very worthwhile Investment >20% year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
12.12.21
-
12.12.22
8.73%
25.12.21

Could be very worthwhile Investment >20% year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€151.40
12.12.21
-
12.12.22
5.67%
25.12.21

Could be very worthwhile Investment >20% year
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.49
12.12.21
-
12.12.22
4.74%
25.12.21

Could be worthwhile Investment >10% per year
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.48
12.12.21
-
12.12.22
25.48%
25.12.21

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.66
12.12.21
-
12.12.22
-1.27%
25.12.21

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Epizyme Inc.

Start price
Target price
Perf. (%)
€2.63
11.12.21
-
11.12.22
-45.63%
08.12.22

Probably not worthwhile Investment
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.24
11.12.21
-
11.12.22
-16.73%
08.12.22

Risky Investment
buy
Senseonics Holdings Inc

Start price
Target price
Perf. (%)
€2.55
10.12.21
€10.00
31.12.23
-63.92%
11.06.22

EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
High Investments for future growth
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€7.05
08.12.21
-
08.12.22
-4.99%
12.12.21

Risky Investment
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€8.61
08.12.21
€10.00
08.12.22
65.85%
09.12.22

Could be worthwhile Investment >10% per year
buy
Aldeyra Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.90
07.12.21
-
07.12.22
4.24%
11.12.21

Risky Investment
buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.60
06.12.21
€2.80
06.12.22
-1.25%
07.12.22

Could be worthwhile Investment >10% per year